Increased production of interleukin 1β and hepatocyte growth factor may contribute to foveolar hyperplasia in enlarged fold gastritis

Gut

Volumn 39, Issue 6, 1996, Pages 787-794

  Yasunaga, Y ^a   Shinomura, Y ^a   Kanayama, S ^a   Higashimoto, Y ^a   Yabu, M ^a   Miyazaki, Y ^a   Kondo, S ^a   Murayama, Y ^a   Nishibayashi, H ^a   Kitamura, S ^a   Matsuzawa, Y ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

enlarged fold gastritis; foveolar hyperplasia; Helicobacter pylori; hepatocyte growth factor; interleukin 1

Indexed keywords

BISMUTH NITRATE; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; MESSENGER RNA; METRONIDAZOLE; SCATTER FACTOR; TETRACYCLINE; TRANSFORMING GROWTH FACTOR ALPHA;

ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DYSPEPSIA; ENDOSCOPY; EPITHELIUM CELL; GASTRITIS; HELICOBACTER PYLORI; HUMAN; HYPERPLASIA; MACROPHAGE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

EID: 8044261415     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.39.6.787     Document Type: Article

References (42)

1. Rohrmann CA Jr, Seaman WB. Nonneoplastic lesions of the stomach. In: Stamathis G, ed. Alimentary tract radiology. St Louis: Mosby, 1989: 551-93.
2. Komorowski RA, Caya JG. Hyperplastic gastropathy: clinico-pathologic correlation. Am J Surg Pathol 1991; 15: 577-85.
3. Wolfsen HC, Carpenter HA, Talley NJ. Menetrier's disease: a form of hypertrophic gastropathy or gastritis? Gastroenterology 1993; 104: 1310-9.
4. Rutten MJ, Dempsey PJ, Solomon TE, Coffey RJ Jr. TGF-α is a potent mitogen for primary cultures of guinea pig gastric mucous epithelial cells. Am J Physiol 1993; 265: G361-9.
5. Takahashi M, Ota S, Shimada T, Hamada E, Kawabe T, Okudaira T, et al. Hepatocyte growth factor is the most potent endogenous stimulant of rabbit gastric epithelial cell proliferation and migration in primary culture. J Clin Invest 1995; 95: 1994-2003.
6. Dempsey PJ, Goldenring JR, Soroka CJ, Modlin IM, McClure RW, Lind CD, et al. Possible role of transforming growth factor α in the pathogenesis of Ménétrier's disease: supportive evidence from humans and transgenic mice. Gastroenterology 1992; 103: 1950-63.
7. Takagi H, Jhappan C, Sharp R, Merlino G. Hypertrophic gastropathy resembling Menetrier's disease in transgenic mice overexpressing transforming growth factor a in the stomach. J Clin Invest 1992; 90: 1161-7.
8. Gherardi E, Sharpe M, Lane K, Sirulnik A, Stoker M. Hepatocyte growth factor/scatter factor (HGF/SF), the c-met receptor and the behaviour of epithelial cells. In: Jones G, Wigley C, Warn R, eds. Symp Soc Exp Biol XLVII Cell behaviour: adhesion and motilily. Cambridge: The Company of Biologists Limited, 1993: 163-81.
9. Wolf HK, Zarnegar R, Michalopoulos GK. Localization of hepatocyte growth factor in human and rat tissues: an immunohistochemical study. Hepatology 1991; 14: 488-94.
10. Sakaguchi H, Seki S, Tsubouchi H, Daikuhara Y, Niitani Y, Kobayashi K. Ultrastructural location of human hepatocyte growth factor in human liver. Hepatology 1994; 19: 1157-63.
11. Yoshinaga Y, Matsuno Y, Fujita S, Nakamura T, Kikuchi M, Shimosato Y, et al. Immunohistochemical detection of hepatocyte growth factor/scatter factor in human cancerous and inflammatory lesions of various organs. Jpn J Cancer Res 1993; 84: 1150-8.
12. Matsumoto K, Okazaki H, Nakamura T. Up-regulation of hepatocyte growth factor gene expression by interleukin-1 in human skin fibroblasts. Biochem Biophys Res Commun 1992; 188: 235-43.
13. Tamura M, Arakaki N, Tsubouchi H, Takada H, Daikuhara Y. Enhancement of human hepatocyte growth factor production by interleukin-1α and 1β and tumor necrosis factor-α by fibroblasts in culture. J Biol Chem 1993; 268: 8140-5.
14. Dinarello CA. Interleukin-1 and interleukin-1 antagonism. Blood 1991; 77: 1627-52.
15. Rathbone BJ, Heatley RV, eds. Helicobacter pylori and gastroduodenal disease. 2nd ed. London: Blackwell Scientific, 1992.
16. Morrison S, Dahms BB, Hoffenberg E, Czinn SJ. Enlarged gastric folds in association with Campylobacter pylori gastritis. Radiology 1989; 171: 819-21.
17. Stolte M, Bätz CH, Eidt S. Giant fold gastritis: a special form of Helicobacter pylori associated gastritis. Z Gastroenterol 1993; 31: 289-93.
18. Yasunaga Y, Shinomura Y, Kanayama S, Yabu M, Nakanishi T, Miyazaki Y, et al. Improved fold width and increased acid secretion after eradication of the organism in Helocobacter pylori associated enlarged fold gastritis. Gut 1994; 35: 1571-4.
19. Stolte M, Bätz CH, Bayerdörffer E, Eidt S. Helicobacter pylori eradication in the treatment and differential diagnosis of giant folds in the corpus and fundus of the stomach. Z Gastroenterol 1995; 33: 198-201.
20. Bayerdörffer E, Ritter MM, Hatz R, Brooks W, Stolte M. Ménétrier's disease and Helicobacter pylori. N Engl J Med 1993; 329: 60.
21. Avunduk C, Navab F, Hampf F, Coughlin B. Prevalence of Helicobacter pylori infection in patients with large gastric folds: evaluation and follow-up with endoscopic ultrasound before and after antimicrobial therapy. Am J Gastroenterol 1995; 90: 1969-73.
22. Press AJ. Practical significance of gastric rugal folds. Am J Roentgenol 1975; 125: 172-83.
23. Misiewicz JJ, Tytgat GNJ, Goodwin CS, Price AB, Sipponen S, Strickland RG, et al. The Sydney system: a new classification of gastritis. Working party reports of the world congresses of gastroenterology; 1990 August 26-31; Sydney. Melbourne: Blackwell Scientific, 1990: 1-10.
24. Pulford KAF, Rigney EM, Micklem KJ, Jones M, Stross WP, Gatter KC, et al. KP1: a new monoclonal antibody that detects a monocyte/macrophage associated antigen in routinely processed tissue sections. J Clin Pathol 1989; 42: 414-21.
25. Mason DY, Cordell JL, Abdulaziz Z, Naiem M, Bordenave G. Preparation of peroxidase: antiperoxidase (PAP) complexes for immunohistological labeling of monoclonal antibodies. J Histochem Cytochem 1982; 30: 1114-22.
26. Haot J, Hamichi L, Wallez L, Mainguet P. Lymphocytic gastritis: a newly described entity: a retrospective endoscopic and histological study. Gut 1988; 29: 1258-64.
27. Waseem NH, Lane DP. Monoclonal antibody analysis of the proliferating nuclear antigen (PCNA). Structural conversation and the detection of a nucleolar form. J Cell Sci 1990; 96: 121-9.
28. Fraser AG, Sim R, Sankey EA, Dhillon AP, Pounder RE. Effect of eradication of Helicobacter pylori on gastric epithelial cell proliferation. Aliment Pharmacol Ther 1994; 8: 167-73.
29. Guesdon J-L, Thérèse T, Avrameas S. The use of avidinbiotin interaction in immunoenzymatic techniques. J Histochem Cytochem 1979; 27: 1131-9.
30. Kondo S, Imamura I, Shinomura Y, Matsuzawa Y, Fukui H. Determination of histidine decarboxylase mRNA in various rat tissues by the polymerase chain reaction. Inflamm Res 1995; 44: 111-5.
31. Kondo S, Shinomura Y, Kanayama S, Higashimoto Y, Kiyohara T, Yasunaga Y, et al. Helicobacter pylon increases gene expression of hepatocyte growth factor in human gastric mucosa. Biochem Biophys Res Commun 1995; 210: 960-5.
32. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenolchloroform extraction. Anal Biochem 1987; 162: 156-9.
33. Crabtree JE, Shallcross TM, Heatley RV, Wyatt JI. Mucosal tumour necrosis factor α and interleukin-6 in patients with Helicobacter pylori associated gastritis. Gut 1991; 32: 1473-7.
34. Sorensen K, Brodbeck U. Assessment of coating-efficiency in ELISA plates by direct protein determination. J Immunol Methods 1986; 95: 291-93.
35. 2 synthesis by the stomach, and retards gastric emptying. Life Sci 1991; 48: 123-34.
36. Tsubouchi H, Niitani Y, Hirono S, Nakayama H, Gohda E, Arakaki N, et al. Levels of the human hepatocyte growth factor in serum of patients with various liver diseases determined by an enzyme-linked immunosorbent assay. Hepatology 1991; 13: 1-5.
37. Tanaka K, Ishikawa E, Ohmoto Y, Hirai Y. Sandwich enzyme immunoassay for human interleukin-1β(hIL-1β) in urine. Clin Chim Acta 1987; 166: 237-46.
38. Yamada A, Matsumoto K, Iwanari H, Sekiguchi K, Kawata S, Matsuzawa Y, et al. Rapid and sensitive enzyme-linked immunosorbent assay for measurement of HGF in rat and human tissues. Biomed Res 1995; 16: 105-14.
39. Karttunen T, Niemelä S, Lehtola J, Heikkilä J, Mäentausta O, Räsänen O. Campylobacter-like organisms and gastritis: histopathology, bile reflux, and gastric fluid composition. Scand J Gastroenterol 1987; 22: 478-86.
40. Wolber RA, Owen DA, Anderson FH, Freeman HJ. Lymphocytic gastritis and giant gastric folds associated with gastrointestinal protein loss. Mod Pathol 1991; 4: 13-5.
41. Varilek GW, Neil GA, Bishop WP. Caco-2 cells express type I interleukin-1 receptors: ligand binding enhances proliferation. Am J Physiol 1994; 267: G1101-7.
42. Sutherland DB, Varilek GW, Neil GA. Identification and characterization of the rat intestinal epithelial cell (IEC-18) interleukin-1 receptor. Am J Physiol 1994; 266: C1198-203.